U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H26N2O2
Molecular Weight 278.3898
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIMETHOCAINE

SMILES

CCN(CC)CC(C)(C)COC(=O)C1=CC=C(N)C=C1

InChI

InChIKey=OWQIUQKMMPDHQQ-UHFFFAOYSA-N
InChI=1S/C16H26N2O2/c1-5-18(6-2)11-16(3,4)12-20-15(19)13-7-9-14(17)10-8-13/h7-10H,5-6,11-12,17H2,1-4H3

HIDE SMILES / InChI

Molecular Formula C16H26N2O2
Molecular Weight 278.3898
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Dimethocaine (DMC, larocaine), a synthetic derivative of cocaine, is a widely distributed "legal high" consumed as a "new psychoactive substance" (NPS), originally was used in the 1930s as an anesthetic, primarily in dentistry, ophthalmology, and otolaryngology. This drug completely inhibits dopamine transporter and has had the potential for abuse. Dimethocaine is intended for forensic and research purposes.

Originator

Curator's Comment: # Hoffmann-La Roche Company

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q01959
Gene ID: 6531.0
Gene Symbol: SLC6A3
Target Organism: Homo sapiens (Human)
1.2 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys.
2005 Dec 15
Patents

Patents

Sample Use Guides

in rhesus monkeys: When responding was stable, dimethocaine (0.030-1.7 mg/kg/ infusion) was substituted for the cocaine training dose. Dimethocaine administration produced higher response rates compared with that of procaine, and was a more potent reinforcer. Drug effects on behavior were related to DAT occupancy in monkey striatum during neuroimaging with positron emission tomography (PET). DAT occupancy was determined by displacement of 8-(2-[(18)F]fluroethyl)2beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane (FECNT). DAT occupancy was between 66 and 82% and <10-41% for doses of dimethocaine and procaine that maintained maximum response rates, respectively. Acute administration of dimethocaine (10-40 mg/kg, IP) significantly increased locomotor activity and time spent on the drug-paired side and reduced the relative number of entries and time spent on the open arms of the plus-maze in mice.
Route of Administration: Intraperitoneal
In Vitro Use Guide
Dimethocaine showed full displacement of [3H]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane 1.5-naphthalenedisulfonate (CFT) binding (0-30 microM tested) and full inhibition of dopamine uptake (0-100 microM tested). Dimethocaine was only slightly less potent than cocaine with an estimated Ki of 1.4 micorM and an IC50 value of 1.2 microM for [3H]CFT binding and dopamine uptake.
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:06:09 GMT 2023
Edited
by admin
on Fri Dec 15 17:06:09 GMT 2023
Record UNII
R3L4A6GOWZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIMETHOCAINE
MI   WHO-DD  
Common Name English
NSC-68927
Code English
DIMETHOCAINE [MI]
Common Name English
1-PROPANOL, 3-(DIETHYLAMINO)-2,2-DIMETHYL-, 4-AMINOBENZOATE (ESTER)
Common Name English
Dimethocaine [WHO-DD]
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-Dimethocaine
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
NCI_THESAURUS C245
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
Code System Code Type Description
NSC
68927
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
SMS_ID
100000079208
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
WIKIPEDIA
Dimethocaine
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
MERCK INDEX
m4512
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY Merck Index
CAS
94-15-5
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
DRUG CENTRAL
3154
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
FDA UNII
R3L4A6GOWZ
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
NCI_THESAURUS
C98208
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
EVMPD
SUB13607MIG
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
EPA CompTox
DTXSID40240185
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
PUBCHEM
7177
Created by admin on Fri Dec 15 17:06:09 GMT 2023 , Edited by admin on Fri Dec 15 17:06:09 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY